Ledger.Open graph →
SEC Form D · Amendment · filed June 21, 2022

NFlection Therapeutics, Inc

Offering
$30.0M
Sold
$20.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Christopher Powala · Boston, MADirectorCorey Goodman · Boston, MADirectorWilliam Hodder · Boston, MAExec · DirectorJosh Grass · Boston, MADirectorKetan Patel · Boston, MADirectorChristine A. Janofsky · SAN FRANCISCO, CAExec · DirectorBlas Jacob Cabrera · Claymont, DEDirectorSuresh Rajan · Westport, CTDirectorJustin Polce · Mountainside, NJDirectorKarlos W. Hanchey · Conyers, GADirectorPaul More · Calgary, Alberta, CanadaDirectorJason Latkowcer · Calgary, Alberta, CanadaExec · DirectorWilliam Gibbs · Calgary, Alberta, CanadaDirectorDouglas Korn · NEW YORK, NYDirectorStuart Lander · Santa Monica, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗